Commissioner Scott Gottlieb of the U.S. Food and Drug Administration (“FDA”) stole the spotlight this past month when he delivered a speech discussing big promises from the agency regarding artificial intelligence (“AI”) in healthcare. “One of the most promising digital health tools is artificial intelligence, particularly efforts that use machine learning,” said Gottlieb when explaining
Latest Post
More Posts
CMS Overhauls Meaningful Use Program
Digital Health Collaboration In The Medical Cannabis Space Announced Amid Legal Uncertainty
New Limits on Pharmaceutical Manufacturer Payments and Gifts to Prescribers in New Jersey
Large Kidney Dialysis Provider Settles with OCR for Multiple HIPAA Breaches
The First Health Privacy Settlements of 2018 Highlight the Ongoing Importance of HIPAA Privacy and Security
Regulating at the Speed of Digital: FDA Implementation of Key Aspects of Digital Health Innovation Action Plan Progressing Quickly
HHS Issues New HIPAA Mental and Behavioral Health Guidance
New Tax Bill and Healthcare
Preliminary Results for Covered Entities Participating in the Phase 2 HIPAA Audit Program
Subscribe: Subscribe via RSS
Blogs
Firm/Org